Behavioral and antinociceptive effects of different psychostimulant drugs in prenatally methamphetamine-exposed rats

Physiological Research

Volumn 61, Issue SUPPL.2, 2012, Pages

  Yamamotova A ^a   Slamberova R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antinociception; Morphine; Plantar test; Prenatal methamphetamine; Psychostimulant drugs

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CENTRAL STIMULANT AGENT; COCAINE; METHAMPHETAMINE; MORPHINE; NARCOTIC AGENT;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGICAL ASPECT; RAT;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; FEMALE; MALE; METHAMPHETAMINE; MORPHINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NARCOTICS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS;

EID: 84873113636     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ALTIER N, STEWART J The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65: 2269-2287, 1999.
2. BANDLER R, SHIPLEY MT Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci 17: 379-389, 1994
3. BANKSON MG, CUNNINGHAM KA 3,4-methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther 297: 846-852, 2001.
4. BECERRA L, BREITER HC, WISE R, GONZALEZ RG, BORSOOK D Reward circuitry activation by noxious thermal stimuli. Neuron 32: 927-946, 2001.
5. BORSOOK D, BECERRA L, CARLEZON WA Jr, SHAW M, RENSHAW P, ELMAN I, LEVINE J Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur J Pain 11: 7-20, 2007.
6. BRANDAO ML, ZANOVELI JM, RUIZ-MARTINEZ RC, OLIVEIRA LC, LANDEIRA-FERNANDEZ J Different patterns of freezing behavior organized in the periaqueductal gray of rats: association with different types of anxiety. Behav Brain Res 188: 1-13, 2008.
7. BUBENIKOVA-VALESOVA V, KACER P, SYSLOVA K, RAMBOUSEK L, JANOVSKY M, SCHUTOVA B, HRUBA L, SLAMBEROVA R Prenatal methamphetamine exposure affects the mesolimbic dopaminergic system and behavior in adult offspring. Int J Dev Neurosci 27: 525-530, 2009.
8. CHEFER VI, DENOROY L, ZAPATA A, SHIPPENBERG TS Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms. Eur J Neurosci 30: 272-278, 2009.
9. CHEN JY, YEH GC, TAO PL, KUO CT, CHEN KB, WEN YR Prenatal exposure to methamphetamine alters the mechanical withdrawal threshold and tonic hyperalgesia in the offspring. Neurotoxicology 31: 432-438, 2010.
10. CRISP T, STALINSKY JL, BOJA JW, SCHECHTER MD The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat. Pharmacol Biochem Behav 34: 497-501, 1989.
11. DALAL S, MELZACK R Psychostimulant drugs potentiate morphine analgesia in the formalin test. J Pain Symptom Manage 16: 230-239, 1998a.
12. DALAL S, MELZACK R Potentiation of opioid analgesia by psychostimulant drugs: a review. J Pain Symptom Manage 16: 245-253, 1998b.
13. FANG F, PROUDFIT HK Spinal cholinergic and monoamine receptors mediate the antinociceptive effect of morphine microinjected in the periaqueductal gray on the rat tail but not the feet. Brain Res 722: 95-108, 1996.
14. FANG F, PROUDFIT HK Antinociception produced by microinjection of morphine in the periaqueductal gray is enhanced in the foot, but not the tail, by intrathecal injection of α1-adrenoreceptor antagonists. Brain Res 790: 14-24, 1998.
15. FRANKLIN KBJ: Analgesia and abuse potential: an accidental association or a common substrate? Pharmacol Biochem Behav 59: 993-1002, 1998
16. JACOBS BL, MARTÍN-CORA FJ, FORNAL CS Activity of medullary serotonergic neurons in freely moving animals. Brain Res Rev 10: 45-52, 2002.
17. JANSSEN SA, ARNTZ A No evidence for opioid-mediated analgesia induced by phobic fear. Behav Res Ther 35: 823-830, 1997.
18. JOHNSON SW, NORTH RA Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488, 1992.
19. KOOB GF Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177-184, 1992.
20. LAPIROT O, MELIN C, MODOLO A, NICOLAS C, MESSAOUDI Y, MONCONDUIT L, ARTOLA A, LUCCARINI P, DALLEL R Tonic and phasic descending dopaminergic controls of nociceptive transmission in the medullary dorsal horn. Pain 152: 1821-1831, 2011.
21. LE BARS D, GOZARIU M, CADDEN SW Animal models of nociception. Pharmacol Rev 53: 597-652, 2001.
22. LEKNES S, TRACEY I A common neurobiology for pain and pleasure. Nat Rev Neurosci 9: 314-320, 2008.
23. LISTER RG Ethologically-based animal models of anxiety disorders. Pharmacol Ther 46: 321-340, 1990.
24. MASON P Central mechanisms of pain modulation. Curr Opin Neurobiol 9: 436-441, 1999.
25. MILLAN MJ Serotonin (5-HT) and pain: a reappraisal of its role in the light of receptor multiplicity. Semin Neurosci 7: 409-419, 1995.
26. MORGAN MJ, FRANKLIN KBJ 6-hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in formalin test but not in the tail flick test. Brain Res 519: 144-149, 1990.
27. MORGAN MJ, FRANKLIN KBJ Dopamine receptors subtypes and formalin test analgesia. Pharmacol Biochem Behav 40: 317-322, 1991.
28. MORGAN MM, FOSSUM EN, STALDING BM, KING MM Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in rats. J Pain 7: 358-366, 2006.
29. MÜLLER CP, CAREY RJ, HUSTON JP, DE SOUZA SILVA MA Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Prog Neurobiol 81: 133-178, 2007.
30. NINAN PT The functional anatomy, neurochemistry, and pharmacology of anxiety. J Clin Psychiatry 60 (Suppl 22): 12-17, 1999.
31. OHMORI T, ABEKAWA T, KOYAMA T The role of glutamate in behavioral and neurotoxic effects of methamphetamine. Neurochem Int 29: 301-307, 1996.
32. OMELCHENKO N, SESACK SR Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area. J Neurosci Res 88: 981-991, 2010.
33. RHUDY JL, MEAGHER W Fear and anxiety: divergent effects on human pain thresholds. Pain 84: 65-75. 2000.
34. ROTHMAN RB, BAUMANN MH, DERSCH CM, ROMERO DV, RICE KC, CAROLL FI, PARTILLA JS Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32-41, 2001.
35. ROTHMAN RB, BAUMANN MH Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479: 23-40, 2003.
36. ROYCHOWDHURY SM, HEINRICHER MM Effects of iontophoretically applied serotonin on three classes of physiologically characterized putative pain modulating neurons in the rostral ventromedial medulla of lightly anesthetized rats. Neurosci Lett 226: 136-138, 1997.
37. SCHAD C, JUSTICE JB, HOLTZMAN SG Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions. J Pharmacol Exp Ther 300: 932-938, 2002.
38. SHOBLOCK JR, SULLIVAN EB, MAISONNEUVE IM, GLICK SD Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 165: 359-369, 2003.
39. WOOD PB Mesolimbic dopaminergic mechanisms and pain control. Pain 120: 230-234, 2006.
40. YAMAMOTOVÁ A, POMETLOVÁ M, HARMATHA J, RAŠKOVÁ H, ROKYTA R The selective effect of Nferuloylserotonins isolated from Leuzea carthamoides on nociception and anxiety in rats. J Ethnopharmacology 112: 368-374, 2007.
41. YAMAMOTOVÁ A, HRUBÁ L, SCHUTOVÁ B, ROKYTA R, ŠLAMBEROVÁ R Perinatal effect of methamphetamine on nociception in adult Wistar rats. Int J Dev Neurosci 29: 85-92, 2011.
42. ZIMMERMANN M Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983.